{"id":58699,"date":"2023-07-21T20:38:56","date_gmt":"2023-07-21T20:38:56","guid":{"rendered":"https:\/\/digitalhealthcoalition.org\/?page_id=58699"},"modified":"2023-07-21T20:39:59","modified_gmt":"2023-07-21T20:39:59","slug":"short-takes-with-mark-bard-dhc-group-guest-nik-kolatkar-vice-president-us-medical-affairs-at-genentech","status":"publish","type":"page","link":"https:\/\/digitalhealthcoalition.org\/?page_id=58699","title":{"rendered":"Short Takes with Mark Bard, DHC Group &#8211; Guest: Nik Kolatkar, Vice President, US Medical Affairs at Genentech"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"58699\" class=\"elementor elementor-58699\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-95a879c elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"95a879c\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-a9d5c01\" data-id=\"a9d5c01\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8babb26 elementor-widget elementor-widget-video\" data-id=\"8babb26\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;video_type&quot;:&quot;vimeo&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<iframe class=\"elementor-video-iframe\" allowfullscreen allow=\"clipboard-write\" title=\"vimeo Video Player\" src=\"https:\/\/player.vimeo.com\/video\/705842525?color&amp;autopause=0&amp;loop=0&amp;muted=0&amp;title=1&amp;portrait=1&amp;byline=1#t=\"><\/iframe>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-82a09d1 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"82a09d1\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3ced06f\" data-id=\"3ced06f\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-168d460 elementor-widget elementor-widget-text-editor\" data-id=\"168d460\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tIn this brief interview with Nik Kolatkar with Genentech, Mark Bard discusses innovation in clinical trials, the rapid uptake of digital health tools within patient populations and the impact on post-marketing strategy. As a leader with insights across the spectrum of pharmaceutical research and commercialization, Nik discusses and shares insights on the topics of interest to marketers thinking about what\u2019s ahead for customer-centric marketing.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-113ea35 elementor-section-full_width elementor-section-content-middle elementor-section-height-default elementor-section-height-default\" data-id=\"113ea35\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-5ca6021\" data-id=\"5ca6021\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-03e6ac5 elementor-widget elementor-widget-testimonial\" data-id=\"03e6ac5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"testimonial.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-testimonial-wrapper\">\n\t\t\t\n\t\t\t\t\t\t<div class=\"elementor-testimonial-meta elementor-has-image elementor-testimonial-image-position-top\">\n\t\t\t\t<div class=\"elementor-testimonial-meta-inner\">\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-testimonial-image\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.linkedin.com\/in\/nkolatkar\"><img decoding=\"async\" src=\"https:\/\/digitalhealthcoalition.org\/wp-content\/uploads\/2023\/07\/Nikheel-Kolatkar.jpeg\" title=\"\" alt=\"\" loading=\"lazy\" \/><\/a>\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-testimonial-details\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-testimonial-name\" href=\"https:\/\/www.linkedin.com\/in\/nkolatkar\">Nik Kolatkar<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-testimonial-job\" href=\"https:\/\/www.linkedin.com\/in\/nkolatkar\">Vice President, US Medical Affairs at Genentech<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e2d9b2d elementor-align-center elementor-widget elementor-widget-button\" data-id=\"e2d9b2d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-lg\" href=\"\/short-takes\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-arrow-left\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Go back to the listing<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>https:\/\/player.vimeo.com\/video\/705842525In this brief interview with Nik Kolatkar with Genentech, Mark Bard discusses innovation in clinical trials, the rapid uptake of digital health tools within patient populations and the impact on post-marketing strategy. As a leader with insights across the spectrum of pharmaceutical research and commercialization, Nik discusses and shares insights on the topics of interest&#8230;<\/p>\n","protected":false},"author":5,"featured_media":0,"parent":24574,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-58699","page","type-page","status-publish","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"In this brief interview with Nik Kolatkar with Genentech, Mark Bard discusses innovation in clinical trials, the rapid uptake of digital health tools within patient populations and the impact on post-marketing strategy. As a leader with insights across the spectrum of pharmaceutical research and commercialization, Nik discusses and shares insights on the topics of interest\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/digitalhealthcoalition.org\/?page_id=58699\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Digital Health Coalition - Moving Innovation Forward\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Short Takes with Mark Bard, DHC Group \u2013 Guest: Nik Kolatkar, Vice President, US Medical Affairs at Genentech - Digital Health Coalition\" \/>\n\t\t<meta property=\"og:description\" content=\"In this brief interview with Nik Kolatkar with Genentech, Mark Bard discusses innovation in clinical trials, the rapid uptake of digital health tools within patient populations and the impact on post-marketing strategy. As a leader with insights across the spectrum of pharmaceutical research and commercialization, Nik discusses and shares insights on the topics of interest\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/digitalhealthcoalition.org\/?page_id=58699\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2023-07-21T20:38:56+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2023-07-21T20:39:59+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Short Takes with Mark Bard, DHC Group \u2013 Guest: Nik Kolatkar, Vice President, US Medical Affairs at Genentech - Digital Health Coalition\" \/>\n\t\t<meta name=\"twitter:description\" content=\"In this brief interview with Nik Kolatkar with Genentech, Mark Bard discusses innovation in clinical trials, the rapid uptake of digital health tools within patient populations and the impact on post-marketing strategy. As a leader with insights across the spectrum of pharmaceutical research and commercialization, Nik discusses and shares insights on the topics of interest\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/digitalhealthcoalition.org\\\/?page_id=58699#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/digitalhealthcoalition.org#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/digitalhealthcoalition.org\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/digitalhealthcoalition.org\\\/?page_id=24574#listItem\",\"name\":\"DHCG Disruptive Dose\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/digitalhealthcoalition.org\\\/?page_id=24574#listItem\",\"position\":2,\"name\":\"DHCG Disruptive Dose\",\"item\":\"https:\\\/\\\/digitalhealthcoalition.org\\\/?page_id=24574\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/digitalhealthcoalition.org\\\/?page_id=58699#listItem\",\"name\":\"Short Takes with Mark Bard, DHC Group &#8211; Guest: Nik Kolatkar, Vice President, US Medical Affairs at Genentech\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/digitalhealthcoalition.org#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/digitalhealthcoalition.org\\\/?page_id=58699#listItem\",\"position\":3,\"name\":\"Short Takes with Mark Bard, DHC Group &#8211; Guest: Nik Kolatkar, Vice President, US Medical Affairs at Genentech\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/digitalhealthcoalition.org\\\/?page_id=24574#listItem\",\"name\":\"DHCG Disruptive Dose\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/digitalhealthcoalition.org\\\/#organization\",\"name\":\"Digital Health Coalition\",\"description\":\"Moving Innovation Forward\",\"url\":\"https:\\\/\\\/digitalhealthcoalition.org\\\/\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/digitalhealthcoalition.org\\\/?page_id=58699#webpage\",\"url\":\"https:\\\/\\\/digitalhealthcoalition.org\\\/?page_id=58699\",\"name\":\"Short Takes with Mark Bard, DHC Group \\u2013 Guest: Nik Kolatkar, Vice President, US Medical Affairs at Genentech - Digital Health Coalition\",\"description\":\"In this brief interview with Nik Kolatkar with Genentech, Mark Bard discusses innovation in clinical trials, the rapid uptake of digital health tools within patient populations and the impact on post-marketing strategy. As a leader with insights across the spectrum of pharmaceutical research and commercialization, Nik discusses and shares insights on the topics of interest\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/digitalhealthcoalition.org\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/digitalhealthcoalition.org\\\/?page_id=58699#breadcrumblist\"},\"datePublished\":\"2023-07-21T20:38:56+00:00\",\"dateModified\":\"2023-07-21T20:39:59+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/digitalhealthcoalition.org\\\/#website\",\"url\":\"https:\\\/\\\/digitalhealthcoalition.org\\\/\",\"name\":\"Digital Health Coalition\",\"description\":\"Moving Innovation Forward\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/digitalhealthcoalition.org\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Short Takes with Mark Bard, DHC Group \u2013 Guest: Nik Kolatkar, Vice President, US Medical Affairs at Genentech - Digital Health Coalition","description":"In this brief interview with Nik Kolatkar with Genentech, Mark Bard discusses innovation in clinical trials, the rapid uptake of digital health tools within patient populations and the impact on post-marketing strategy. As a leader with insights across the spectrum of pharmaceutical research and commercialization, Nik discusses and shares insights on the topics of interest","canonical_url":"https:\/\/digitalhealthcoalition.org\/?page_id=58699","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/digitalhealthcoalition.org\/?page_id=58699#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/digitalhealthcoalition.org#listItem","position":1,"name":"Home","item":"https:\/\/digitalhealthcoalition.org","nextItem":{"@type":"ListItem","@id":"https:\/\/digitalhealthcoalition.org\/?page_id=24574#listItem","name":"DHCG Disruptive Dose"}},{"@type":"ListItem","@id":"https:\/\/digitalhealthcoalition.org\/?page_id=24574#listItem","position":2,"name":"DHCG Disruptive Dose","item":"https:\/\/digitalhealthcoalition.org\/?page_id=24574","nextItem":{"@type":"ListItem","@id":"https:\/\/digitalhealthcoalition.org\/?page_id=58699#listItem","name":"Short Takes with Mark Bard, DHC Group &#8211; Guest: Nik Kolatkar, Vice President, US Medical Affairs at Genentech"},"previousItem":{"@type":"ListItem","@id":"https:\/\/digitalhealthcoalition.org#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/digitalhealthcoalition.org\/?page_id=58699#listItem","position":3,"name":"Short Takes with Mark Bard, DHC Group &#8211; Guest: Nik Kolatkar, Vice President, US Medical Affairs at Genentech","previousItem":{"@type":"ListItem","@id":"https:\/\/digitalhealthcoalition.org\/?page_id=24574#listItem","name":"DHCG Disruptive Dose"}}]},{"@type":"Organization","@id":"https:\/\/digitalhealthcoalition.org\/#organization","name":"Digital Health Coalition","description":"Moving Innovation Forward","url":"https:\/\/digitalhealthcoalition.org\/"},{"@type":"WebPage","@id":"https:\/\/digitalhealthcoalition.org\/?page_id=58699#webpage","url":"https:\/\/digitalhealthcoalition.org\/?page_id=58699","name":"Short Takes with Mark Bard, DHC Group \u2013 Guest: Nik Kolatkar, Vice President, US Medical Affairs at Genentech - Digital Health Coalition","description":"In this brief interview with Nik Kolatkar with Genentech, Mark Bard discusses innovation in clinical trials, the rapid uptake of digital health tools within patient populations and the impact on post-marketing strategy. As a leader with insights across the spectrum of pharmaceutical research and commercialization, Nik discusses and shares insights on the topics of interest","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/digitalhealthcoalition.org\/#website"},"breadcrumb":{"@id":"https:\/\/digitalhealthcoalition.org\/?page_id=58699#breadcrumblist"},"datePublished":"2023-07-21T20:38:56+00:00","dateModified":"2023-07-21T20:39:59+00:00"},{"@type":"WebSite","@id":"https:\/\/digitalhealthcoalition.org\/#website","url":"https:\/\/digitalhealthcoalition.org\/","name":"Digital Health Coalition","description":"Moving Innovation Forward","inLanguage":"en-US","publisher":{"@id":"https:\/\/digitalhealthcoalition.org\/#organization"}}]},"og:locale":"en_US","og:site_name":"Digital Health Coalition - Moving Innovation Forward","og:type":"article","og:title":"Short Takes with Mark Bard, DHC Group \u2013 Guest: Nik Kolatkar, Vice President, US Medical Affairs at Genentech - Digital Health Coalition","og:description":"In this brief interview with Nik Kolatkar with Genentech, Mark Bard discusses innovation in clinical trials, the rapid uptake of digital health tools within patient populations and the impact on post-marketing strategy. As a leader with insights across the spectrum of pharmaceutical research and commercialization, Nik discusses and shares insights on the topics of interest","og:url":"https:\/\/digitalhealthcoalition.org\/?page_id=58699","article:published_time":"2023-07-21T20:38:56+00:00","article:modified_time":"2023-07-21T20:39:59+00:00","twitter:card":"summary_large_image","twitter:title":"Short Takes with Mark Bard, DHC Group \u2013 Guest: Nik Kolatkar, Vice President, US Medical Affairs at Genentech - Digital Health Coalition","twitter:description":"In this brief interview with Nik Kolatkar with Genentech, Mark Bard discusses innovation in clinical trials, the rapid uptake of digital health tools within patient populations and the impact on post-marketing strategy. As a leader with insights across the spectrum of pharmaceutical research and commercialization, Nik discusses and shares insights on the topics of interest"},"aioseo_meta_data":{"post_id":"58699","title":null,"description":null,"keywords":[],"keyphrases":{"focus":[],"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2023-07-21 20:38:36","updated":"2026-09-01 00:20:46","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/digitalhealthcoalition.org\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/digitalhealthcoalition.org\/?page_id=24574\" title=\"DHCG Disruptive Dose\">DHCG Disruptive Dose<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tShort Takes with Mark Bard, DHC Group \u2013 Guest: Nik Kolatkar, Vice President, US Medical Affairs at Genentech\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/digitalhealthcoalition.org"},{"label":"DHCG Disruptive Dose","link":"https:\/\/digitalhealthcoalition.org\/?page_id=24574"},{"label":"Short Takes with Mark Bard, DHC Group &#8211; Guest: Nik Kolatkar, Vice President, US Medical Affairs at Genentech","link":"https:\/\/digitalhealthcoalition.org\/?page_id=58699"}],"_links":{"self":[{"href":"https:\/\/digitalhealthcoalition.org\/index.php?rest_route=\/wp\/v2\/pages\/58699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/digitalhealthcoalition.org\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/digitalhealthcoalition.org\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/digitalhealthcoalition.org\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/digitalhealthcoalition.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=58699"}],"version-history":[{"count":4,"href":"https:\/\/digitalhealthcoalition.org\/index.php?rest_route=\/wp\/v2\/pages\/58699\/revisions"}],"predecessor-version":[{"id":58703,"href":"https:\/\/digitalhealthcoalition.org\/index.php?rest_route=\/wp\/v2\/pages\/58699\/revisions\/58703"}],"up":[{"embeddable":true,"href":"https:\/\/digitalhealthcoalition.org\/index.php?rest_route=\/wp\/v2\/pages\/24574"}],"wp:attachment":[{"href":"https:\/\/digitalhealthcoalition.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=58699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}